A Randomized, Double-blind Study to Compare the Pharmacokinetics Between ABP 234 and Keytruda® (Pembrolizumab) in Subjects with Early-stage Non squamous Non-small Cell Lung Cancer as Adjuvant Treatment Following Resection and Platinum-based Chemotherapy (PK-SS)
Early-stage Non squamous Non-small Cell Lung Cancer
Raja Perempuan Zainab II Hospital, Kota Bharu
PRINCIPAL INVESTIGATOR
AZZA BINTI OMAR
CONTACT
SC: Nora Diana binti Kamaruzaman, Nur Azriena Binti Muhammad
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer (BGB-LC-201)
Beacon Hospital Sdn Bhd
PRINCIPAL INVESTIGATOR
Dr Azura Rozila Ahmad
drazura@beaconhospital.com.my
03-77860846
A Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) (INTerpath-002)
Non-small Cell Lung Cancer
Sarawak General Hospital
PRINCIPAL INVESTIGATOR
VOON PEI JYE
CONTACT
SC: Lim Li Fang
National Cancer Institute (IKN)
PRINCIPAL INVESTIGATOR
WONG YOKE FUI, Florence
CONTACT
SC: Anis Hazirah Asmali Jauhari
Hospital Pulau Pinang
PRINCIPAL INVESTIGATOR
TAN AI LIAN
CONTACT
SC: Nur Shaphira Sholikin
Tengku Ampuan Afzan Hospital
PRINCIPAL INVESTIGATOR
MEGAT RAZEEM B. ABDUL RAZAK
CONTACT
SC: Syafiqah Hanani Mohd Shahidin